Case Report
Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
Table 1
Flucytosine dosing recommendations in renal impairment
a [
3,
5,
8–
10].
|
Flucytosine dosing of 100 mg/kg/day (normal renal function) |
Flucytosine dosing of 150 mg/kg/day (normal renal function) | CrCL (mL/min) | Dose | CrCL (mL/min) | Dose |
| >50 | 25 mg/kg every 6 hours | >40, >50 | 37.5 mg/kg every 6 hours | 10–50 | 25 mg/kg every 12–24 hours | 20–40, 10–50 | 37.5 mg/kg every 12–24 hours | <10 | 25 mg/kg every 24–48 hours | <20, <10 | 37.5 mg/kg every 24–48 hours | Hemodialysis | Single, supplemental doses of 20–50 mg/kg after dialysis sessions | Hemodialysis | Single, supplemental doses after dialysis sessions | CRRT | No specific recommendations | CRRT | CVVHD/CVVH: 37.5 mg/kg every 12–24 hours |
|
|
CrCL: creatinine clearance, CRRT: continuous renal replacement therapy, and CVVHD/CVVH: continuous venovenous hemodialysis/continuous venovenous hemofiltration.
|